Comprehensive population-based survey of migraine in Japan: results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study

References

• Lipton RB, Bigal ME, Kolodner K, et al. The family impact of migraine: population-based studies in the USA and UK. Cephalalgia. 2003;23(6):429–440.
   PubMed Web of Science ®Google Scholar
• Blumenfeld AM, Bloudek LM, Becker WJ, et al. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the Second International Burden of Migraine Study (IBMS-II). Headache. 2013;53(4):644–655.
   PubMed Web of Science ®Google Scholar
• Steiner TJ, Stovner LJ, Jensen R, et al. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1):137.
   PubMed Web of Science ®Google Scholar
• Sakai F, Igarashi H. Prevalence of migraine in Japan: a nationwide survey. Cephalalgia. 1997;17(1):15–22.
   PubMed Web of Science ®Google Scholar
• Takeshima T, Ishizaki K, Fukuhara Y, et al. Population‐based door‐to‐door survey of migraine in Japan: the Daisen study. Headache. 2004;44(1):8–19.
   PubMed Web of Science ®Google Scholar
• Takeshima T, Wan Q, Zhang Y, et al. Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature. J Headache Pain. 2019;20(1):111.
   PubMed Web of Science ®Google Scholar
• Shimazawa R, Ando Y, Hidaka S, et al. Development of triptans in Japan: bridging strategy based on the ICH-E5 guideline. J Health Sci. 2006;52(4):443–449.
   Google Scholar
• Ueda K, Ye W, Lombard L, et al. Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi Migraine Disease Specific Programme. J Headache Pain. 2019;20(1):68.
   PubMed Web of Science ®Google Scholar
• Kikui S, Chen Y, Todaka H, et al. Burden of migraine among Japanese patients: a cross-sectional national health and wellness survey. J Headache Pain. 2020;21(1):110.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Araujo AB, Nicholson RA, et al. Patterns of diagnosis, consultation, and treatment of migraine in the US: results of the OVERCOME study. Headache. 2019;59(S1):2–3.
   Google Scholar
• Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41(7):646–657.
   PubMed Web of Science ®Google Scholar
• US Census Bureau [Internet]. International Data Base (IDB): Japan 2020. Suitland (MD): US Census Bureau; 2019 [cited 2019 Dec 12]. Available from: https://www.census.gov/data-tools/demo/idb/#/country?YR_ANIM=2019&FIPS_SINGLE=JA&COUNTRY_YEAR=2019&dashPages=BYAGE&ageGroup=1Y
   Google Scholar
• Statistics Bureau, Ministry of Internal Affairs and Communications of Japan [Internet]. National census: basic tabulation of population. Tokyo (Japan): Statistics Bureau; 2021 [cited 2021 May 7]. Available from: https://www.e-stat.go.jp/stat-search/files?layout=datalist&cycle=0&toukei=00200521&tstat=000001080615&tclass1=000001089055&tclass2=000001089056&tclass3val=0&stat_infid=000031473211
   Google Scholar
• Stewart WF, Lipton RB, Dowson AJ, et al. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20–S28.
   PubMed Web of Science ®Google Scholar
• Stewart WF, Lipton RB, Kolodner K, et al. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia. 1999;19(2):107–114.
   PubMed Web of Science ®Google Scholar
• Iigaya M, Sakai F, Kolodner KB, et al. Reliability and validity of the Japanese Migraine Disability Assessment (MIDAS) Questionnaire. Headache. 2003;43(4):343–352.
   PubMed Web of Science ®Google Scholar
• Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–365.
   PubMed Web of Science ®Google Scholar
• Stovner LJ, Nichols E, Steiner TJ, et al. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954–976.
   PubMed Web of Science ®Google Scholar
• Igarashi H, Ueda K, Jung S, et al. Social burden of people with the migraine diagnosis in Japan: evidence from a population-based cross-sectional survey. BMJ Open. 2020;10(11):e038987.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343–349.
   PubMed Web of Science ®Google Scholar
• Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222.
   PubMed Web of Science ®Google Scholar
• Kim BK, Chu MK, Yu SJ, et al. Burden of migraine and unmet needs from the patients’ perspective: a survey across 11 specialized headache clinics in Korea. J Headache Pain. 2021;22(1):45.
   PubMed Web of Science ®Google Scholar
• American Headache Society. The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache. 2019;59(1):1–18.
   PubMed Web of Science ®Google Scholar
• Silberstein S, Loder E, Diamond S, et al. Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) Study. Cephalalgia. 2007;27(3):220–229.
   PubMed Web of Science ®Google Scholar
• Piccinni C, Cevoli S, Ronconi G, et al. A real-world study on unmet medical needs in triptan-treated migraine: prevalence, preventive therapies and triptan use modification from a large Italian population along two years. J Headache Pain. 2019;20(1):74.
   PubMed Web of Science ®Google Scholar
• Sacco S, Lampl C, Maassen van den Brink A, et al. Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance. J Headache Pain. 2021;22(1):39.
   PubMed Web of Science ®Google Scholar
• Araki N, Takeshima T, Ando N, et al. Clinical practice guideline for chronic headache 2013. Neurol Clin Neurosci. 2019;7(5):231–259.
   Web of Science ®Google Scholar
• Wong LP, Alias H, Bhoo-Pathy N, et al. Impact of migraine on workplace productivity and monetary loss: a study of employees in banking sector in Malaysia. J Headache Pain. 2020;21(1):68.
   PubMed Web of Science ®Google Scholar
• Blumenfeld AM, Varon SF, Wilcox TK, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31(3):301–315.
   PubMed Web of Science ®Google Scholar
• Vo P, Fang J, Bilitou A, et al. Patients’ perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom. J Headache Pain. 2018;19(1):82.
   PubMed Web of Science ®Google Scholar